Prof Stephen Evans
Emeritus Professor of Pharmacoepidemiology
United Kingdom
My first degree was in physics and chemistry and included a year in the US doing physics and philosophy. Having worked in computing I did the MSc in Medical Statistics at LSHTM and worked in statistics and computing at The London Hospital and Medical College for 25 years, leaving there in 1995 as Prof of Medical Statistics, and was made Hon. Prof at LSHTM. I was then at the UK Medicines Control Agency (now MHRA) and briefly at Quintiles where I mainly worked on the Bristol Royal Infirmary Inquiry. I joined LSHTM part-time on retirement in 2002. I was (until June 2018) a European Commission appointed independent Expert member of the Pharmacovigilance (Drug Safety) and Risk Assessment Committee at the European Medicines Agency. I was President of the International Society of Pharmacoepidemiology for 2010/2011. From October 2022 I am Emeritus and do not act as a supervisor of PhD students.
I am the statistician to the CEPI meta-Data and Safety Monitoring Board overseeing all trials of vaccines funded by CEPI for disease mainly affecting low and middle-income countries. I continue with minor involvement in the OpenSafely collaboration. I was convenor of the Statistics Expert Group at the Infected Blood Inquiry which reported in May 2024.
Affiliations
Centres
Teaching
I helped start the LSHTM short course in pharmacoepidemiology and pharmacovigilance and do a small amount of teaching on that course and the Practical Pharmacoepidemiology short course. I have also contributed to the DL MSc in Clinical Trials and the MSc in Medical Statistics.
Research
Effects of medicines, both drugs and vaccines, is my major interest. Assessment of effiacy, safety and risk in trials and epidemiological studies, especially in electronic health records, are the main topics.
I have suggested methods for use in analysis of spontaneous reports of suspected adverse reactions to drugs and vaccines, and continue to contribute to this field, known as pharmacovigilance.
I am also interested in detection of scientific fraud and misconduct, especially in clinical trials.
I have extensive experience in data monitoring committees for both drug and vaccine trials.